In:
Cancer, Wiley, Vol. 128, No. 12 ( 2022-06-15), p. 2288-2297
Abstract:
The progression‐free survival benefit of upfront autotransplantation in patients with myeloma was similar irrespective of cytogenetic‐risk subgroup. The overall survival benefit of upfront autotransplantation in myeloma was predominantly derived by patients who had high‐risk cytogenetics.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v128.12
Language:
English
Publisher:
Wiley
Publication Date:
2022
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1
Permalink